Dosage Forms

Articles

Catalent has acquired Micron Technologies, a provider of particle size engineering technologies.

Catalent Acquires Micron Technologies, Adds Particle Engineering Capabilities to Portfolio

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Pharmaceutical Technology Europe spoke with Piero Iamartino, R&D director at Micro-Macinazione, about the role of micronization in pharmaceutical manufacturing.

Micronization as a Bioavailability Enhancement Tool

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Micronization and other processes are used to obtain optimal particle characteristics for pulmonary and oral solid-dosage delivery.

Need for Particle Engineering Increases

Jon Faulkes, formerly business development manager, formulation development, Aesica Pharmaceuticals

Emma J Mickley, PhD, vice-president, corporate business development, Aesica Pharmaceuticals

Advances in engineered particles and the subsequent reduction in the API mass required to achieve a therapeutic dose can lead to a reduction in side effects.

Fit for the Lung?

Mark Copley is Sales Director at Copley Scientific.

The role of add-on devices and how they affect drug delivery with a pressurized metered dose inhaler.

Exploring Newly Introduced Methods for Testing MDIs with Add-On Devices

Experts discuss factors affecting drug delivery to the lungs and key considerations when developing inhalation formulations.

Pulmonary Drug Delivery—Particle Engineering for Inhaled Therapeutics

Products enable testing in accordance with methods described in new USP monograph.

Copley Scientific Launches Two New Products for MDI Testing

In this sponsored podcast, Adam Stuart, Senior Design Engineer at 3M Drug Delivery Systems, discusses the role of dose counters for metered dose inhalers and the technical challenges companies can face when adding this feature to their inhaler products.

The Benefits and Challenges of Dose Counters for Metered Dose Inhalers

Stada licenses 3M's transdermal technology for a fentanyl patch.

3M Licenses Transdermal Patch for Stada

Intertek is now offering comprehensive services for the development of orally inhaled and intranasal drug products (OINDPs) for both small molecules and biologics.

Specialty Dosage Drugs